Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CVM-1118 |
Synonyms | |
Therapy Description |
CVM-1118 (foslinanib) is a small molecule that inhibits tumor vasculogenic mimicry, potentially resulting in decreased proliferation and increased apoptosis of tumor cells (PMID: 26808163). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CVM-1118 | Foslinanib|TRX818|TRX-818|TRX 818|CVM1118|CVM 1118 | CVM-1118 (foslinanib) is a small molecule that inhibits tumor vasculogenic mimicry, potentially resulting in decreased proliferation and increased apoptosis of tumor cells (PMID: 26808163). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|